Development of Modified Combined Apgar Scoring System for Evaluation of Infants in the Delivery Room
1 other identifier
observational
800
1 country
1
Brief Summary
Apgar scoring system has been widely used for the evaluation of the infant's postnatal condition. As conventional Apgar scoring system is affected by gestational age and resuscitative efforts, there is a need for development of new scoring systems for the assessment in the delivery room. Herein, Modified Combined Apgar scoring system which includes two new parameters (cord blood pH and targeted oxygen saturation level) has been developed and the utility of this modified system was compared with Conventional and Combined Apgar scoring systems for prediction of hospitalization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 11, 2016
CompletedStudy Start
First participant enrolled
May 1, 2017
CompletedFirst Posted
Study publicly available on registry
May 25, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 5, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2018
CompletedAugust 13, 2019
August 1, 2019
10 months
May 11, 2016
August 12, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Modified Combined Apgar scoring
The predictive value of Modified Combined Apgar scoring for hospitalization of infants
10 months
Interventions
Modified APGAR scoring system
Eligibility Criteria
Term and Preterm Neonates delivered in our hospital
You may qualify if:
- Term neonates Preterm neonates Parental approval
You may not qualify if:
- Major congenital/chromosomal abnormalities Lack of informed consent Stillbirth Outborn infants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kanuni Sultan Suleyman Training and Research Hospital
Istanbul, Kucukcekmece, 34303, Turkey (Türkiye)
Study Officials
- STUDY DIRECTOR
Seda Yilmaz Semerci, MD
Kanuni Sultan Suleyman Training and Research Hospital
- STUDY DIRECTOR
Gokhan Buyukkale, MD
Neonatologist
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, MD,PhD
Study Record Dates
First Submitted
May 11, 2016
First Posted
May 25, 2017
Study Start
May 1, 2017
Primary Completion
March 5, 2018
Study Completion
May 1, 2018
Last Updated
August 13, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share